 VALSARFEC D
|
Fecofar
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.x 30 | $32.348,93 | (29/06/26) |
| PAMI |
|
| AF $14.984,77 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $12.948,99 |
|
|
|
|
| 160/25 mg comp.x 30 | $37.578,32 | (29/06/26) |
| PAMI |
|
| AF $16.368,65 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $13.323,00 |
|
|
|
|
| 80/12.5 mg comp.x 30 | $27.866,59 | (29/06/26) |
| PAMI |
|
| AF $13.933,30 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $10.107,59 |
|
|
|
|
| 80/12.5 mg comp.x 28 | $25.880,73 | (29/06/26) |
|
|
|
| 160/12.5 mg comp.x 28 | $30.043,61 | (29/06/26) |
| PAMI |
|
| AF $15.021,81 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $14.276,40 |
|
|
|
|
| 160/25mg comp.x 28 | $34.900,36 | (29/06/26) |
| PAMI |
|
| AF $17.450,18 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $19.133,15 |
|
|
|
|
| |
